Shares

10 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2024

May 09, 2024

BUY
$85.37 - $115.44 $196,351 - $265,512
2,300 New
2,300 $245,000
Q2 2022

Aug 05, 2022

SELL
$117.13 - $176.59 $959,060 - $1.45 Million
-8,188 Closed
0 $0
Q1 2022

May 12, 2022

SELL
$126.46 - $235.05 $11.7 Million - $21.7 Million
-92,153 Reduced 91.84%
8,188 $1.41 Million
Q4 2021

Feb 10, 2022

SELL
$225.82 - $368.51 $15.5 Million - $25.3 Million
-68,562 Reduced 40.59%
100,341 $25.5 Million
Q3 2021

Nov 12, 2021

SELL
$221.9 - $484.47 $15.4 Million - $33.6 Million
-69,255 Reduced 29.08%
168,903 $65 Million
Q2 2021

Aug 12, 2021

SELL
$129.91 - $234.98 $13.4 Million - $24.2 Million
-102,939 Reduced 30.18%
238,158 $56 Million
Q1 2021

May 13, 2021

BUY
$109.18 - $185.98 $28 Million - $47.7 Million
256,641 Added 303.88%
341,097 $44.7 Million
Q4 2020

Feb 16, 2021

BUY
$65.74 - $169.86 $1.38 Million - $3.58 Million
21,048 Added 33.19%
84,456 $8.82 Million
Q3 2020

Nov 12, 2020

BUY
$54.34 - $94.85 $1.35 Million - $2.35 Million
24,801 Added 64.24%
63,408 $4.49 Million
Q2 2020

Aug 13, 2020

BUY
$29.67 - $80.0 $1.15 Million - $3.09 Million
38,607 New
38,607 $2.48 Million

Others Institutions Holding MRNA

About Moderna, Inc.


  • Ticker MRNA
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 391,200,000
  • Market Cap $14.4B
  • Description
  • Moderna, Inc., a biotechnology company, discovers, develops, and commercializes messenger RNA therapeutics and vaccines for the treatment of infectious diseases, immuno-oncology, rare diseases, cardiovascular diseases, and auto-immune diseases in the United States, Europe, and internationally. Its respiratory vaccines include COVID-19, flu, resp...
More about MRNA
Track This Portfolio

Track Connor, Clark & Lunn Investment Management Ltd. Portfolio

Follow Connor, Clark & Lunn Investment Management Ltd. and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Connor, Clark & Lunn Investment Management Ltd., based on Form 13F filings with the SEC.

News

Stay updated on Connor, Clark & Lunn Investment Management Ltd. with notifications on news.